Elicio Therapeutics Inc (ELTX)
10.01
+0.63
(+6.72%)
USD |
NASDAQ |
May 17, 16:00
10.01
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Accounts Payable (Quarterly): 4.369M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.369M |
| September 30, 2023 | 4.406M |
| June 30, 2023 | 4.265M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.805M |
| March 31, 2021 | 2.429M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.429M
Minimum
Mar 2021
4.406M
Maximum
Sep 2023
3.655M
Average
4.265M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
| Immuneering Corp | 2.271M |
| Outlook Therapeutics Inc | 4.363M |
| Amylyx Pharmaceuticals Inc | 21.45M |
| NovaBay Pharmaceuticals Inc | 1.117M |
| Palatin Technologies Inc | 3.443M |